...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Investment Banker?

"(Have heard about six prospective suiters for several years now...maybe 2022 is our year?)"

Were those words out of sideshow donnys mouth? 

He has proven over & over again that he doesn't have what it takes & it's really hard to deny that he hasn't been a complete failure other than negotiating his wage & compensation(s).

It's so hard to believe the board(s) have tolerated this hack of almost everything Biotech & beyond! 

You ever get the feeling everything will be scooped up/stolen from right underneath him/US? 

Share
New Message
Please login to post a reply